Identification of Two Exosomal miRNAs in Circulating Blood of Cancer Patients by Using Integrative Transcriptome and Network Analysis

Noncoding RNA. 2022 May 12;8(3):33. doi: 10.3390/ncrna8030033.

Abstract

Exosomes carry molecules of great biological and clinical interest, such as miRNAs. The contents of exosomes vary between healthy controls and cancer patients. Therefore, miRNAs and other molecules transported in exosomes are considered a potential source of diagnostic and prognostic biomarkers in cancer. Many miRNAs have been detected in recent years. Consequently, a substantial amount of miRNA-related data comparing patients and healthy individuals is available, which contributes to a better understanding of the initiation, development, malignancy, and metastasis of cancer using non-invasive sampling procedures. However, a re-analysis of available ncRNA data is rare. This study used available data about miRNAs in exosomes comparing healthy individuals and cancer patients to identify possible global changes related to the presence of cancer. A robust transcriptomic analysis identified two common miRNAs (miR-495-3p and miR-543) deregulated in five cancer datasets. They had already been implicated in different cancers but not reported in exosomes circulating in blood. The study also examined their target genes and the implications of these genes for functional processes.

Keywords: cancer; extracellular vesicles; miRNA.

Grants and funding

This research was funded by the Instituto Nacional de Cancerología Grant Number XRPM:C19010300-454 (to J.A.R.), a Colombian Ministry of Sciences scholarship (to A.R.-R.), and Grant Number IV-FPC007 from the Universidad del Rosario, Bogotá (to V.E.V.).